Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In weight-management studies, confirmed acute pancreatitis occurred in 0.2% of people on tirzepatide and 0.2% on placebo
Typically, most users can cycle it from 8 to 12 weeks
During the early weeks of treatment, when doses are gradually increased to minimise gastrointestinal side effects, appetite suppression may not yet be fully established
The Food and Drug Administration (FDA) approved Wegovy for chronic weight management in adults with obesity or those who have at least one weight related condition
US$ 24.66
US$ 24.80
US$ 28.36
US$ 25.89
US$ 26.07
US$ 26.30
